JPMorgan analyst Jessica Fye reiterated an Overweight rating and $311.00 price target on BeiGene Ltd. (NASDAQ: ONC)The analyst comments "We ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments

BofA Securities Upgrades BeiGene Ltd. (ONC) to BuyMarch 3, 2025 4:17 AM Form 4 BeiGene, Ltd. For: Feb 28 Filed by: BAKER JULIANFebruary 28, 2025 9:28 PM BeiGene Ltd. (ONC) PT Raised to $311 at JPMorganFebruary 28, 2025 8:25 AM BeiGene Ltd. (ONC) PT Raised to $348 at GuggenheimFebruary 28, 2025 7:48 AM BeiGene Ltd. (ONC) PT Raised to $348 at Citizens JMP February 28, 2025 4:20 AM BeiGene Ltd. (ONC) PT Raised to $334 at TD CowenFebruary 27, 2025 6:04 PM BeiGene Ltd. (ONC) PT Raised to $308 at JefferiesFebruary 27, 2025 3:36 PM BeiGene, Ltd. (ONC) Tops Q4 EPS by 77c, provides guidanceFebruary 27, 2025 6:03 AM BeiGene Announces Fourth Quarter and Full Year 2024 Financial Results and Business UpdatesFebruary 27, 2025 6:00 AM